France· FR:60271248
TERCIAN 100 mg, comprimé pelliculé sécable
A cyamemazine product containing tartrate de cyamémazine, registered in France by ATNAHS PHARMA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TARTRATE DE CYAMÉMAZINE
- Manufacturer
- ATNAHS PHARMA FRANCE
- Country
- France (FR)
- ATC code
- N05AA06
- ATC class
- Cyamemazine
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip133400931919926plaquette(s) PVC-Aluminium de 25 comprimé(s)EUR 11.67
- cip133400957464257plaquette(s) PVC aluminium de 50 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05AA06
Cyamemazine, as other registers publish it.
- FranceCYAMEMAZINE ARROW 100 mg, comprimé pelliculé sécableARROW GENERIQUES
- FranceCYAMEMAZINE ARROW 25 mg, comprimé pelliculé sécableARROW GENERIQUES
- FranceCYAMEMAZINE BIOGARAN 100 mg, comprimé pelliculé sécableBIOGARAN
- FranceCYAMEMAZINE BIOGARAN 25 mg, comprimé pelliculé sécableBIOGARAN
- FranceCYAMEMAZINE VIATRIS 100 mg, comprimé pelliculé sécableVIATRIS SANTE
- FranceCYAMEMAZINE VIATRIS 25 mg, comprimé pelliculé sécableVIATRIS SANTE
- FranceTERCIAN 40 mg/ml, solution buvable en gouttesATNAHS PHARMA FRANCE
- FranceTERCIAN 50 mg/5 ml, solution injectable en ampouleATNAHS PHARMA FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Ciamemazina Generis, Tercian
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88cafe89-9a92-497b-b9cf-57d9ea760c85 GET /v1/drugs/88cafe89-9a92-497b-b9cf-57d9ea760c85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60271248",
"date_amm": "1986-10-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TARTRATE DE CYAMÉMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cyamemazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.